According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.90. In 2022 the company made an earnings per share (EPS) of -ยฃ1.89 a decrease over its 2021 EPS that were of -ยฃ1.30.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ1.99 | 5.26% |
2022 | -ยฃ1.89 | 45.73% |
2021 | -ยฃ1.30 | -23.36% |
2020 | -ยฃ1.69 | -41.05% |
2019 | -ยฃ2.87 | -76.95% |
2018 | -ยฃ12.45 | 45.03% |
2017 | -ยฃ8.59 | -42.54% |
2016 | -ยฃ14.94 | -3.82% |
2015 | -ยฃ15.54 | -0.76% |
2014 | -ยฃ15.65 | 29.41% |
2013 | -ยฃ12.10 | 0% |
2012 | -ยฃ12.10 | -9.73% |
2011 | -ยฃ13.40 | 1312.5% |
2010 | -ยฃ0.95 | -95.79% |
2009 | -ยฃ22.51 | -49.64% |
2008 | -ยฃ44.71 | -82.64% |
2007 | -ยฃ257.58 | -44.98% |
2006 | -ยฃ468.19 | 1270.83% |
2005 | -ยฃ34.15 | 33.33% |
2004 | -ยฃ25.62 | -10% |
2003 | -ยฃ28.46 | -16.67% |
2002 | -ยฃ34.15 | -38.46% |
2001 | -ยฃ55.50 | -4.88% |
2000 | -ยฃ58.35 | -81.66% |
1999 | -ยฃ318.06 | -87.2% |
1998 | -ยฃ2,484 | 206.39% |
1997 | -ยฃ810.68 | 13.02% |
1996 | -ยฃ717.31 |